Journal
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 3, Issue 1, Pages 52-56Publisher
SPRINGER
DOI: 10.1007/s11481-007-9091-1
Keywords
cocaine; blood-brain barrier; CCL2; HIV
Categories
Funding
- NCRR NIH HHS [RR016443] Funding Source: Medline
- NIDA NIH HHS [DA020392-01] Funding Source: Medline
Ask authors/readers for more resources
One of the hallmark features underlying the pathogenesis of HIV encephalitis is the disruption of blood-brain barrier (BBB). Cocaine, often abused by HIV-infected patients, has been suggested to worsen the HIV-associated dementia (HAD) via unknown mechanisms. The objective of the present study was to explore the effects of cocaine on BBB permeability using human brain microvascular endothelial cells (HBMECs). Additionally, because the chemokine CCL2 and its receptor CCR2 play a crucial role in the recruitment of inflammatory cells into the central nervous system in HAD brains, we tested for the effect of cocaine in modulating the CCL2/CCR2 axis. Our findings suggest that exposure of HBMECs to cocaine correlated with the breakdown of ZO-1 tight junction protein and reorganization of the cytoskeleton resulting in stress fiber formation. Furthermore, cocaine also modulated upregulation of the CCL2/CCR2 axis in monocytes. These findings conform to the multifaceted effects of cocaine leading to accelerated progression of HIV-1 neuropathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available